SEC Filing Summary: CNO Financial Group, Inc.
Business Context and Reporting Period
This filing is a Form 13F Information Table submitted by CNO Financial Group, Inc. for the reporting period ending December 31, 2015. The document discloses the company's holdings of U.S. equity securities and certain debt instruments as of the quarter-end date. It does not contain operational financial statements for CNO Financial Group itself.
Key Financial Metrics and Portfolio Composition
The filing details a portfolio of 18 distinct holdings with a total reported value of approximately $306.6 million (sum of Column 4 values). The portfolio is diversified across equities, corporate bonds, and exchange-traded funds (ETFs).
- Largest Holdings by Value:
- SPDR S&P 500 ETF Trust: $126.3 million (619,675 shares)
- iShares Core U.S. Aggregate Bond ETF: $119.7 million (1,108,300 shares)
- WellPoint Inc. Note 2.750%: $2.9 million (1,500,000 principal)
- Danaher Corp. Del Note: $2.7 million (1,000,000 principal)
- Asset Classes: The portfolio includes significant exposure to broad market indices (S&P 500, Aggregate Bonds) and specific corporate debt (Bristol-Myers Squibb, Gilead Sciences, WellPoint).
- Voting Authority: CNO Financial Group reported Sole voting authority for all listed equity positions. No shared or none voting authority was reported for the equity holdings.
Material Changes
The filing text provided is a static snapshot of holdings as of December 31, 2015. It does not provide comparative data against the prior quarter (September 30, 2015) or year-over-year changes. Therefore, material changes in position size or composition cannot be determined from this document alone.
Guidance, Outlook, and Risks
As a Form 13F filing, this document does not contain management commentary, forward-looking guidance, risk factors, or contingency disclosures. It is a regulatory disclosure of investment positions only. The filing includes a standard disclaimer that the SEC has not reviewed the information for accuracy or completeness.
Investor Verification Checklist
- Verify the total portfolio value against CNO Financial Group's 10-Q or 10-K filings for Q4 2015 to confirm the proportion of assets represented by these specific holdings.
- Confirm the classification of the "Note" holdings (e.g., Bristol-Myers Squibb, Danaher, Gilead, WellPoint) to determine if they are held for trading or available-for-sale.
- Review the prior quarter's Form 13F (filed in November 2015) to calculate actual turnover and material changes in the S&P 500 and Aggregate Bond ETF positions.
- Check for any subsequent amendments to this filing that might correct the reported values or share counts.